United Therapeutics CEO Executes Pre-Arranged Share Sales and Option Exercises
Martine A. Rothblatt, Chairperson and CEO of United Therapeutics Corp (NASDAQ:UTHR), executed a series of transactions on July 22, 2026, involving the sale of common stock and the exercise of stock options. These activities were conducted under a pre-arranged Rule 10b5-1 trading plan. Concurrently, the company received premarket approval for its Lu…